Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Martina Bebin

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Clinical Pharmacology and Therapeutics|August 31, 2021
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant EpilepsyBrittney H Davis, T Mark Beasley, Michelle Amaral, et al.
Pediatric Neurology|August 3, 2021
Epilepsy Is Heterogeneous in Early-Life Tuberous Sclerosis ComplexS Katie Z Ihnen, Jamie K Capal, Paul S Horn, et al.
Epilepsia|October 29, 2024
Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous sclerosis complexS Katie Z Ihnen, Samuel Alperin, Jamie K Capal, et al.
Pediatrics|November 5, 2017
Presentation and Diagnosis of Tuberous Sclerosis Complex in InfantsPeter E Davis, Rajna Filip-Dhima, Georgios Sideridis, et al.
JAMA Neurology|December 21, 2020
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical TrialElizabeth A Thiele, E Martina Bebin, Hari Bhathal, et al.
Plos One|September 8, 2018
Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosisJohn J Bissler, Norio Nonomura, Klemens Budde, et al.
Computers in Biology and Medicine|May 6, 2026
A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complexCancan Zhang, Runqiu Wang, Jamie K Capal, et al.
Pediatric Neurology|April 29, 2023
Epilepsy Severity Is Associated With Head Circumference and Growth Rate in Infants With Tuberous Sclerosis ComplexAlexis Levine, Peter Davis, Bo Zhang, et al.
Pediatric Neurology|March 5, 2026
Early Vocal Development in Tuberous Sclerosis Complex Predicts Language but Not Autism OutcomesTanjala T Gipson, Edina R Bene, Ching-Chi Yang, et al.
Pediatric Neurology|August 7, 2025
Developmental Trajectories of Adaptive Functioning and Behavior Problems in Children With Co-Occurring Tuberous Sclerosis Complex and Autism Spectrum Disorder, With and Without SeizuresLynnel C Goodman, Melissa A Richard, John P Woodhouse, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|August 31, 2021
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant EpilepsyBrittney H Davis, T Mark Beasley, Michelle Amaral, et al.
Pediatric Neurology|August 3, 2021
Epilepsy Is Heterogeneous in Early-Life Tuberous Sclerosis ComplexS Katie Z Ihnen, Jamie K Capal, Paul S Horn, et al.
Epilepsia|October 29, 2024
Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous sclerosis complexS Katie Z Ihnen, Samuel Alperin, Jamie K Capal, et al.
Pediatrics|November 5, 2017
Presentation and Diagnosis of Tuberous Sclerosis Complex in InfantsPeter E Davis, Rajna Filip-Dhima, Georgios Sideridis, et al.
JAMA Neurology|December 21, 2020
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical TrialElizabeth A Thiele, E Martina Bebin, Hari Bhathal, et al.
Plos One|September 8, 2018
Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosisJohn J Bissler, Norio Nonomura, Klemens Budde, et al.
Computers in Biology and Medicine|May 6, 2026
A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complexCancan Zhang, Runqiu Wang, Jamie K Capal, et al.
Pediatric Neurology|April 29, 2023
Epilepsy Severity Is Associated With Head Circumference and Growth Rate in Infants With Tuberous Sclerosis ComplexAlexis Levine, Peter Davis, Bo Zhang, et al.
Pediatric Neurology|March 5, 2026
Early Vocal Development in Tuberous Sclerosis Complex Predicts Language but Not Autism OutcomesTanjala T Gipson, Edina R Bene, Ching-Chi Yang, et al.
Pediatric Neurology|August 7, 2025
Developmental Trajectories of Adaptive Functioning and Behavior Problems in Children With Co-Occurring Tuberous Sclerosis Complex and Autism Spectrum Disorder, With and Without SeizuresLynnel C Goodman, Melissa A Richard, John P Woodhouse, et al.
Pageof 9